60-year
History
120+
Geographies
250+
Patents
IMV Technologies is the world leader in animal artificial insemination, embryo transfer and veterinary imaging.
A Montagu business
- Clear global market leader with 25-50% global market shares across key verticals
- Resilient and growing underlying market, expected to grow by 4% p.a. until 2025
- Significant additional growth avenues via product innovation and expansion into adjacent markets
- High revenue visibility with c. 50% of revenue recurring in nature (and a higher percentage of profits)
Accelerating growth and driving product innovation
We are supporting management to:
- Continue investment in R&D in order to accelerate the realisation of current and new projects, and continue to gain market share by increasing IMV’s competitive edge
- Continue IMV’s acquisition strategy in order to penetrate new verticals and expand in key geographies
- Invest in human capital to support the next phase of growth
- Invest in processes and systems to improve the organisation’s agility
